Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

被引：0

作者：

Simoes, Catia ^{[1
]}

Villar, Sara ^{[1
]}

Ariceta, Benat ^{[1
]}

Garces, Juan-Jose ^{[1
]}

Burgos, Leire ^{[1
]}

Alignani, Diego ^{[1
]}

Sarvide, Sarai ^{[1
]}

Martinez-Cuadron, David ^{[2
]}

Bergua, Juan-Miguel ^{[3
]}

Vives, Susana ^{[4
]}

Algarra, Lorenzo ^{[5
]}

Tormo, Mar ^{[6
]}

Martinez, Pilar ^{[7
]}

Serrano, Josefina ^{[8
]}

Herrera, Pilar ^{[9
]}

Ramos, Fernando ^{[10
]}

Salamero, Olga ^{[11
]}

Lavilla, Esperanza ^{[12
]}

Gil, Cristina ^{[13
]}

Lopez-Lorenzo, Jose-Luis ^{[14
]}

Vidriales, Maria-Belen ^{[15
,16
]}

Chillon, Carmen ^{[15
,16
]}

Labrador, Jorge ^{[17
]}

Falantes, Jose-Francisco ^{[18
]}

Sayas, Maria-Jose ^{[19
]}

Ayala, Rosa ^{[7
]}

Martinez-Lopez, Joaquin ^{[7
]}

Pierola, Ana Alfonso ^{[1
]}

Calasanz, Maria-Jose ^{[1
,20
]}

Prosper, Felipe ^{[1
]}

San-Miguel, Jesus F. ^{[1
]}

Sanz, Miguel A. ^{[2
]}

Paiva, Bruno ^{[1
]}

Montesinos, Pau ^{[2
]}

机构：

[1] Clin Univ Navarra, Ctr Invest Med Aplicada CIMA, CCUN, IDISNA,CIBER ONC CB16 12 00369 & CB16 12 00489, Pamplona, Spain

[2] Hosp Univ & Politecn La Fe, CIBER ONC CB16 12 00284, Valencia, Spain

[3] Hosp San Pedro Alcantara, Caceres, Spain

[4] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

[5] Hosp Gen Albacete, Albacete, Spain

[6] Hosp Clin Univ Valencia, Valencia, Spain

[7] Univ Complutense Madrid, Hosp Univ 12 Octubre, CNIO, CIBERONC,I 12, Madrid, Spain

[8] Hosp Univ Reina Sofia, IMIBIC, Cordoba, Spain

[9] Hosp Univ Ramon y Cajal, Madrid, Spain

[10] Hosp Univ Leon, Leon, Spain

[11] Hosp Univ Vall dHebron, Barcelona, Spain

[12] Hosp Univ Lucus Augusti, Lugo, Spain

[13] Hosp Gen Univ Alicante, Alicante, Spain

[14] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

[15] Hosp Univ Salamanca, CIBER ONC CB16 12 00233, IBSAL, Salamanca, Spain

[16] Ctr Invest, Salamanca, Spain

[17] Univ Isabel I, Hosp Univ Burgos, Burgos, Spain

[18] Complejo Hosp Virgen Rocio, Seville, Spain

[19] Hosp Dr Peset, Valencia, Spain

[20] Univ Navarra, CIMA LAB Diagnost, Pamplona, Spain

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷 / 06期

关键词：

OLDER PATIENTS; THERAPY; RISK;

D O I：

10.1111/bjh.18815

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1239 / 1244

页数：6

共 50 条

[1] Transcriptional and Genomic Characterization of Measurable Residual Disease (MRD) Cells in Acute Myeloid Leukemia (AML)
Patricia Simoes, Catia
Villar, Sara
Ariceta, Benat
Garces, Juan-Jose
Burgos, Leire
Alignani, Diego
Sarai, Sarvide
Martinez-Cuadron, David
Bergua Burgues, Juan Miguel
Vives, Susana
Algarra, Lorenzo
Tormo, Mar
Martinez Sanchez, Pilar
Serrano, Josefina
Herrera, Pilar
Ramos, Fernando
Salamero, Olga
Lavilla, Esperanza
Gil, Cristina
Lopez Lorenzo, Jose Luiz
Belen Vidriales, Maria
Chillon Santos, Maria Carmen
Labrador, Jorge
Falantes, Jose F.
Jose Sayas, Maria
Ayala, Rosa
Martinez-Lopez, Joaquin
Alfonso-Pierola, Ana
Jose Calasanz, Maria
Prosper, Felipe
San-Miguel, Jesus
Sanz, Miguel A.
Montesinos, Pau
Paiva, Bruno
BLOOD, 2022, 140 : 2270 - 2272
[2] Measurable residual disease testing in acute myeloid leukaemia
C S Hourigan
R P Gale
N J Gormley
G J Ossenkoppele
R B Walter
Leukemia, 2017, 31 : 1482 - 1490
[3] Measurable residual disease testing in acute myeloid leukaemia
Hourigan, C. S.
Gale, R. P.
Gormley, N. J.
Ossenkoppele, G. J.
Walter, R. B.
LEUKEMIA, 2017, 31 (07) : 1482 - 1490
[4] Applying molecular measurable residual disease testing in acute myeloid leukaemia
Krigstein, Michael
Iland, Harry J.
Wei, Andrew H.
PATHOLOGY, 2023, 55 (01) : 1 - 7
[5] Next-generation sequencing for measurable residual disease detection in acute myeloid leukaemia
Ghannam, Jack
Dillon, Laura W.
Hourigan, Christopher S.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (01) : 77 - 85
[6] DETECTION OF MEASURABLE RESIDUAL DISEASE IN ADULTS WITH ACUTE LEUKAEMIA
Galtseva, I., V
Davydova, Y. O.
Parovichnikova, E. N.
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (04): : 460 - 472
[7] Minimal residual disease in acute myeloid leukaemia
Yin, JAL
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (01) : 119 - 135
[8] Minimal residual disease in acute myeloid leukaemia
Christopher S. Hourigan
Judith E. Karp
Nature Reviews Clinical Oncology, 2013, 10 : 460 - 471
[9] Minimal residual disease in acute myeloid leukaemia
Hourigan, Christopher S.
Karp, Judith E.
NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (08) : 460 - 471
[10] Evaluating measurable residual disease in acute myeloid leukemia
Ravandi, Farhad
Walter, Roland B.
Freeman, Sylvie D.
BLOOD ADVANCES, 2018, 2 (11) : 1356 - 1366

← 1 2 3 4 5 →